Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 205,564,893 papers from all fields of science
Search
Sign In
Create Free Account
SB 211475
Known as:
SB-211475
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
2 relations
Broader (2)
Carbazoles
Propanolamines
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
1998
1998
SB 211475, a metabolite of carvedilol, reduces infarct size after myocardial ischemic and reperfusion injury in rabbits.
H. Brunvand
,
G. Liu
,
X. Ma
,
T. Yue
,
R. Ruffolo
,
G. Feuerstein
European journal of pharmacology
1998
Corpus ID: 4550334
1998
1998
Effects of a hydroxylated metabolite of the β‐adrenoreceptor antagonist, carvedilol, on post‐ischaemic splanchnic tissue injury
T. Christopher
,
B. Lopez
,
X. Ma
,
G. Feuerstein
,
R. Ruffolo
,
T. Yue
British journal of pharmacology
1998
Corpus ID: 24734712
Reactive oxygen species have been demonstrated to play a critical role in post‐ischaemic tissue injury. The present experiment…
Expand
Highly Cited
1994
Highly Cited
1994
SB 211475, a metabolite of carvedilol, a novel antihypertensive agent, is a potent antioxidant.
T. Yue
,
P. J. McKenna
,
+4 authors
G. Feuerstein
European journal of pharmacology
1994
Corpus ID: 4554953
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
,
Terms of Service
, and
Dataset License
ACCEPT & CONTINUE